BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6173190)

  • 1. [Behavior of secretin-pancreozymin-stimulated pancreatic secretion, gallbladder contraction and choleresis after somatostatin administration].
    von Kleist D; Zschiedrich M; Stopik D; Hampel KE
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(5):219-24. PubMed ID: 6173190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.
    Kayasseh L; Gyr K; Stalder GA; Rittmann WW; Girard J
    Horm Res; 1978; 9(3):176-84. PubMed ID: 640582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction induced by secretin, cholecystokinin-pancreozymin and carbachol administration.
    Lankisch PG; Fölsch UR; Köstering H; Creutzfeldt W
    Z Gastroenterol Verh; 1976; (10):51-5. PubMed ID: 64052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of somatostatin on canine exocrine pancreas secretion stimulated by pancreozymin, secretin or test meal].
    Kayasseh L; Stalder GA; Gyr K; Rittmann WW; Girard J
    Schweiz Med Wochenschr; 1977 Apr; 107(15):541-2. PubMed ID: 857313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.
    Vatn MH; Schrumpf E; Hanssen KF; Myren J
    J Endocrinol Invest; 1980; 3(3):279-82. PubMed ID: 6159391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central action of cholecystokinin-pancreozymin and secretin on pancreatic enzyme secretion].
    Rozin DG
    Fiziol Zh SSSR Im I M Sechenova; 1981 Sep; 67(9):1364-9. PubMed ID: 6170532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suppressive effect of somatostatin on secretin-CCK-PZ-stimulated endocrine and exocrine pancreatic function in man (author's transl)].
    Regal H; Fink M; Luger T; Ogris E; Fischer M; Irsigler K
    Wien Klin Wochenschr; 1977 Sep; 89(17):580-6. PubMed ID: 410166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of somatostatin on basal and stimulated pancreatic secretion in the rat.
    Fölsch UR; Lankisch PG; Creutzfeldt W
    Digestion; 1978; 17(3):194-203. PubMed ID: 640271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
    Regan PT; Go VL; DiMagno EP
    J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced inhibitory effect of somatostatin on the exocrine function of the pancreas and on serum insulin (IRI) levels in chronic relapsing pancreatitis.
    Czyzyk A; Szadkowski M; Muszyński J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():155-9. PubMed ID: 6085315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans.
    You CH; Rominger JM; Chey WY
    Gastroenterology; 1983 Jul; 85(1):40-5. PubMed ID: 6303892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pancreatic secretion in domestic sprue].
    Otte M; Thurmayr GR; Dageförde J; Thurmayr R; Forell MM
    Dtsch Med Wochenschr; 1985 Feb; 110(7):259-64. PubMed ID: 2578924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme secretion during intravenous fat infusion.
    Burns GP; Stein TA
    JPEN J Parenter Enteral Nutr; 1987; 11(1):60-2. PubMed ID: 2434670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exocrine pancreatic function in insulin-dependent diabetes mellitus.
    Lankisch PG; Manthey G; Otto J; Koop H; Talaulicar M; Willms B; Creutzfeldt W
    Digestion; 1982; 25(3):211-6. PubMed ID: 6186557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [State of the exocrine function of the pancreas during human aging].
    Valenkevich LN
    Vopr Pitan; 1976; (1):11-5. PubMed ID: 969354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic exocrine secretion in normal subjects studied by continuous infusion of pancreozymin and secretin.
    Schütz HB; Andersson S; Lagerlöf H
    Scand J Gastroenterol; 1969; 4(7):597-602. PubMed ID: 5383686
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile secretion in man. The effects of somatostatin, vasoactive intestinal peptide and secretin.
    Nyberg B
    Acta Chir Scand Suppl; 1990; 557():1-40. PubMed ID: 1981635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man.
    Dollinger HC; Raptis S; Pfeiffer EF
    Horm Metab Res; 1976 Jan; 8(1):74-8. PubMed ID: 765255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.